Abstract
Materials and Methods:
We administered a comprehensive cognitive battery to 120 seropositive subjects (101 men) who reported alcohol consumption in the preceding 90 days. Participants were excluded if they were seeking alcohol treatment or showed evidence of dementia. Using the computerized CogState battery, we measured performance in executive functioning, verbal learning/memory, visual learning/memory, attention, working memory, and psychomotor speed. The computerized Iowa Gambling Task was used to assess decision-making.
Results:
The HIV + subjects showed significantly slower psychomotor speed than a normative sample. Although across most domains, neurocognitive performance in our sample was not significantly associated with recent alcohol consumption, performance on the CogState measures of visual memory and attention was significantly poorer with a higher level of drinking in the past 3 months and a current alcohol use disorder, respectively.
Conclusions:
Although cognitive weaknesses were detectable among these non-treatment-seeking HIV + drinkers, the level of alcohol consumption was not a primary determinant of neurocognitive performance in this group. A comprehensive profile analysis may be most valuable for detecting cognitive strengths and weaknesses given the heterogeneity of this population. Longitudinal studies are needed to examine the potential additive or synergistic effects of heavy drinking and HIV seropositivity on cognitive performance. 
H
IV is associated with changes in neurocognitive functioning, the hallmark of which is frontostriatal deficits, as subcortical pathways involving the prefrontal cortex seem especially susceptible to HIV-related damage. Thus, a central aspect of HIV-related cognitive impairment is a pattern of deficits in executive functioning (EF). 1, 2 In cross-sectional studies, individuals with HIV exhibited poorer performance on tasks of problem solving, cognitive flexibility, planning, inhibition, and decision making than healthy control groups. [3] [4] [5] [6] Mild-to-moderate learning and memory impairment with a mixed encoding and retrieval profile are also frequently observed in HIV+ individuals consistent with frontostriatal dysfunction. 3, [6] [7] [8] [9] Learning and encoding difficulties likely reflect impairment in the mechanisms of EF, such as faulty search and retrieval strategies (eg, failure to use semantic clustering on list-learning tasks). 3, 6 Even HIV+ individuals treated with highly active antiretroviral therapy (HAART), despite having acceptable CD4 counts and undetectable viral loads, can display cognitive dysfunction. [10] [11] [12] Nonetheless, patterns of cognitive deficits tend to be heterogeneous across HIV+ individuals and may be moderated by other factors, including depression, head injury, age, premorbid intelligence quotient (IQ), education, and the use of alcohol and drugs.
of HIV infection, is associated with deficits in learning, memory, and EF, 14 and prior research suggests that HIV+ heavy drinkers may show greater deficits in EF, verbal and visuospatial learning and memory, and psychomotor speed than individuals with either HIV infection or alcohol use disorder (AUD) alone. [15] [16] [17] [18] However, studies examining the effect of alcohol use on neurocognitive functioning in HIV infection have produced variable results, or have been specific to a single cognitive domain.
Because heavy drinking and neurocognitive impairment are prevalent and debilitating factors in seropositive individuals, we examined the extent to which the level of alcohol consumed was associated with global cognitive functioning in HIV+ individuals. To do so, we used a computerized neuropsychological battery to examine the associations between recent alcohol use and cognitive performance in a sample of HIV+ individuals. In contrast to prior studies that examined performance in a single cognitive domain, we used a comprehensive battery to assess EF, visual and verbal memory, attention, psychomotor processing speed (reaction time), working memory, and decision-making. We also examined a range of demographic and premorbid characteristics that could affect cognition.
We hypothesized that, in this sample of HIV+ men and women, given the shared vulnerability to frontostriatal dysfunction associated with both HIV and alcohol use, performance on tests of EF and memory would be inversely related to the level of alcohol consumed in the 3 months preceding study participation.
MATERIALS AND METHODS

Overview
We used a cross-sectional design in which participants underwent a psychiatric diagnostic interview, completed self-report measures, and were administered a cognitive test battery. Prospective participants were screened by telephone to assess basic inclusion and exclusion criteria. Eligible individuals were invited for an in-person assessment and, if they had a zero breath alcohol concentration, were asked to give written, informed consent and underwent an interview and neuropsychological testing by a trained research evaluator. Participants were compensated for their time and transportation costs.
Participants
HIV+ individuals were included in the study if they were 18 to 70 years old, were currently taking HAART, reported having consumed alcohol in the past 90 days, and had a verbal IQ of Z80. All participants provided written informed consent to participate in the study, which was approved by the Institutional Review Board of the University of Pennsylvania Perelman School of Medicine.
Individuals were excluded from participation if, on the basis of history or psychiatric examination, they met criteria for a severe psychiatric disorder (psychosis, mania, and active suicidal ideation or intent) or a current Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) diagnosis of dependence on a drug other than nicotine or cannabis. To eliminate potential effects on cognitive performance, individuals taking antipsychotic, mood stabilizing, or sedative/hypnotic medications were also excluded. Lastly, individuals with significant cognitive impairment [on the basis of MiniMental State Examination (MMSE) score], a history of a traumatic brain injury, or another potential confounding neurological disorder (eg, seizure disorder) were excluded.
Recruitment
The majority of subjects were identified through a database maintained by the University of Pennsylvania Center for AIDS Research. Other recruitment sources (in descending order of importance) were referrals from other HIV treatment settings in Philadelphia or from medical providers in the University of Pennsylvania Health System, word of mouth, flyers posted in health care and community settings, and media advertisements. We had initial telephone contact with 842 
Assessments
Sociodemographic Information
The socio demographic information included age, sex, race/ethnicity, household income, years of education, and marital status.
Reading Ability and General Intellectual Function
The Wechsler Test of Adult Reading (WTAR 20 ), a well-validated, brief assessment of intellectual functioning, was used to estimate full-scale IQ on the basis of irregularly spelled word reading. The WTAR full-scale IQ, which includes age and race adjustments, served as a measure of baseline intellectual functioning, as it is regarded as stable and generally unaffected by cognitive decline.
Gross Cognitive Function
The MMSE 19 was used to screen for significant cognitive impairment, which was defined by a score of <25 (maximum possible = 30).
Psychiatric and Drug Use Disorder Diagnoses
Modules from the Mini International Neuropsychiatric Interview 21 were used to identify the presence of current and lifetime mania, psychotic disorders, suicidal risk, and drug use disorders according to DSM-IV criteria. 22 
AUD Diagnoses
The Structured Clinical Interview for DSM-IV 23 was used to diagnose lifetime and current DSM-IV alcohol abuse or dependence.
Alcohol-related Measures
The Timeline Followback Interview 24 was used to estimate alcohol consumption and drinking patterns for the 90 days before the study visit. This widely used instrument shows high testretest reliability and construct validity in the assessment of alcohol use. 25, 26 We measured recent drinking on the basis of evidence that a cross-sectional assessment of cognitive functioning is impacted most strongly by proximal heavy drinking. 27 
Recent Cannabis Use
The timeline followback (TLFB) 24 was adapted to measure the frequency of cannabis use during the 30 days before the interview. Because recent cannabis use can affect cognition, 28, 29 we used this measure as a covariate in the analysis of cognitive performance.
HAART Medication Adherence
The TLFB 24 was also adapted to elicit retrospective self-reports of adherence to HAART in the 30 days before the study visit. We measured the total number of days with 100% medication adherence and the overall percentage of adherence in the past month, with the latter serving as a covariate in the analysis of cognitive performance.
Patient Health Questionnaire (PHQ-9)
The PHQ-9 is a 9-item, selfadministered depression measure that is reliable and valid. 
Decision Making
We used the Iowa Gambling Task, 32 a computerized gambling task, to simulate real-world decision making. In this task, the participant begins with $2000 of ''play'' money and is instructed to maximize profit over 100 trials by selecting cards from any of 4 decks. On the basis of profit and loss potential, 2 of the decks are termed ''advantageous'' and 2 are ''disadvantageous.'' We examined the overall difference between total advantageous and total disadvantageous selections across five 20-card blocks. A positive score was indicative of advantageous decision making, whereas a negative score represented disadvantageous decision making. This was also evaluated as an outcome measure.
Analytic Approach
First, we assessed each variable for normality of distribution using the Shapiro-Wilk test. Consistent with CogState guidelines, 2 participants were removed from the analysis for having not completed the GMLT. Because CogState automatically log 10 transforms reaction time, we reverse transformed the outcomes of the detection and identification tasks to facilitate their interpretation.
To provide a comparison group of healthy controls with which to compare CogState performance in our sample, we used a large database of published CogState scores previously collected from healthy individuals (Cogstate Ltd., Cogstate Normative Data for Adults; October 2013). The norms were divided into 4 age bins: 18 to 34, 35 to 49, 50 to 59, and 60 to 69. Using the population mean and SD provided for each CogState task, we created ageadjusted z-scores for each participant within each of the cognitive domains assessed in the current study: psychomotor speed, attention, working memory, visual memory, verbal learning/ memory, and EF. Within each cognitive domain, we calculated the mean z-score and SD for our sample.
Drinking level was defined in 2 ways: (1) self-reported heavy drinking days (HDDs) in the previous 90 days (defined as >3 drinks/day for women and >4 drinks/day for men) and (2) presence of current alcohol abuse or dependence (AUD). Because of the highly skewed distribution of HDDs, the sample was stratified into 3 groups: light (no HDDs), moderate (1 to 24 HDDs), and heavy drinkers (25+ HDDs). Presence or absence of a current AUD was used as a binary measure. Sample characteristics were examined across both drinking measures using Jonckheere-Terpstra tests for continuous measures and w 2 statistics for categorical variables.
Associations between drinking and cognitive performance were assessed in 3 ways. Cognitive characteristics were examined by the ordinal HDD drinking measure using Jonckheere-Terpstra tests for non-normal distributions taking into account the ordering of the outcome. The relationship between current AUD and cognitive performance was also assessed using Jonckheere-Terpstra tests. Lastly, multiple generalized linear models (GLMs) were used to determine the relation between drinking (predictor variable) and CogState task performance (outcome), adjusting for age, race, PHQ-9 score, WTAR IQ score, and recent cannabis use. For the models with a speed measure as the outcome (ie, detection and identification tasks), GLMs with gamma distributions and log links were used. For the models with a count measure as the outcome (ie, one-back memory, shopping list-immediate and delayed recall, card learning tasks, GMLT), either Poisson or negative binomial models with log links were used. The natural log of the total number of responses was used as the offset for these models, using Pearson estimates for dispersion scaling when necessary.
The model with decision-making score as the outcome was fit with a normally distributed GLM. All analyses were conducted using SAS version 9.4 (Cary, NC).
RESULTS
Sample Characteristics
A description of the study sample is provided in Table 1 . Because the data were largely non-normal in distribution, we present medians with interquartile ranges (IQR), unless otherwise indicated. Participants were 21 to 66 years old, with a median of 49 years (IQR = 11.0). The sample was predominantly male (n = 101, 84%), and most self-identified as non-Hispanic black/ African American (n = 84, 71%). Participants had completed a median of 13. The sample was comprised primarily of moderate drinkers (n = 63, 53%), though individuals who engaged in light and very heavy drinking were also represented. Participants drank on a median of 29 days (IQR = 41.0) in the 90-day recall period before their study visit. The median number of drinks per drinking day was 3.8 (IQR = 4.1) and for HDDs it was 3 (IQR = 19.0), although 38% of the sample (n = 45) reported having 0 or 1 HDD. One-third of the sample had both a lifetime and a current diagnosis of alcohol dependence (n = 40, 33.6%) and 3.4% had both a lifetime and a current diagnosis of alcohol abuse (n = 4). Further, 16.8% had a lifetime, but no current diagnosis of alcohol dependence (n = 20), and 11.8% had a lifetime, but no current diagnosis of alcohol abuse (n = 14). Just over one-third of the sample (n = 41; 34.5%) had neither a lifetime nor a current AUD diagnosis.
As would be expected, there was a significant association between a current AUD diagnosis (either abuse or dependence) and self-reported drinking level (P<0.0001). Among light drinkers, 3.6% (n = 1) had a current AUD diagnosis; among moderate drinkers, 38.1% (n = 24) had a current AUD diagnosis; and among heavy drinkers 65.5% (n = 19) had a current AUD diagnosis. Most participants had very low scores on the PHQ-9 (median = 3.0; IQR = 6.5), with 86% of the sample scoring in the minimal or mild range of depression, 8% in the moderate range, 4% in the moderately severe range, and 2% in the severely depressed range. Half of the sample reported very high ( >99%) adherence to their HAART medication regimen (IQR = 8.5) and this was significantly inversely correlated with PHQ-9 depression score [Spearman r = -0.37; P<0.0001].
When stratified by self-reported drinking level, moderate and heavy drinkers were more likely to be African American and unemployed and to have fewer years of education, lower annual income, lower estimated premorbid IQ, greater depression scores, and poorer HAART adherence than light drinkers. The distribution of light drinkers was nearly equal in African Americans and non-Hispanic whites. Comparing the subgroups on the basis of a current AUD diagnosis, those with an AUD were also more likely to be African American and to have fewer years of education, lower annual income, greater depression scores, poorer decision-making skills, and poorer HAART adherence than those with a current AUD diagnosis.
Mean Cognitive Performance and CogState Normative Data
As shown in Figure 1 , the lowest mean z-score in our sample, and the only cognitive task for which mean performance was >1 SD below the mean, was for reaction time on the CogState Detection Task of psychomotor speed (mean = 1.16; SD = 1.07). Performance on the GMLT was the second lowest zscore (mean = 0.93; SD = 2.09), but at <1 SD below the mean, it was within normal limits. Overall, the pattern of neuropsychological performance in this sample of HIV+ drinkers was modestly 
Alcohol Use and Cognitive Performance
Self-reported drinking level was not associated with any of the measures of cognitive performance, though a current AUD diagnosis showed some associations in unadjusted analyses ( Table 2) . Individuals with a current AUD had a significantly slower median psychomotor speed, made significantly more errors on the GMLT, and were more likely to have poorer decisionmaking scores on the IGT than those without a current AUD diagnosis. However, these predictors were not significant in multivariable modeling (Table 3) . Interestingly, after controlling for covariates, we found that individuals with a current AUD diagnosis performed significantly more poorly on the attention task (P = 0.01). After adjusting for age, race, IQ, PHQ-9 score, and recent cannabis use, self-reported drinking was significantly associated with cognitive functioning only in the visual memory model, where individuals with moderate drinking provided fewer correct responses than light drinkers (P = 0.02).
DISCUSSION
We examined neurocognitive performance in an HIV+ sample that reported drinking during the 90 days before study entry, but were not seeking treatment for AUD and did not meet criteria for dementia, to examine the relations between drinking level or the presence of a current AUD and performance on a comprehensive cognitive assessment. Overall, the only areas in which neurocognitive performance in the sample was significantly associated with alcohol use were visual memory/ learning and attention. Although psychomotor speed, EF, and decisionmaking were significantly associated with the presence of a current AUD diagnosis in unadjusted analyses, these findings did not hold in multivariate modeling, potentially a consequence of low power because of a small sample 
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www.addictiondisorders.com size. Alternatively, it is possible that these data accurately reflect the lack of a relationship between alcohol and cognitive performance in HIV. The unadjusted findings, however, are consistent with previous studies showing an adverse effect of heavy alcohol use on cognition in HIV+ individuals. [15] [16] [17] [18] 33 The greater evidence of the effects on cognitive functioning of an AUD diagnosis than drinking level may also reflect an underreporting of drinking level among heavier drinkers. That is, individuals with a current AUD may have acknowledged alcohol-related symptoms, but underreported their drinking on the TLFB interview. Future research should include an examination of specific cognitive processes, such as mechanisms of learning and memory, in larger samples of HIV+ heavy drinkers to permit the differentiation of HIV-related and alcohol-related effects. Clinically, cognitive changes in HIV+ individuals who drink alcohol are likely best detected with a comprehensive battery, allowing for intraindividual profile analysis of cognitive strengths and weaknesses. Advantages of using CogState and the IGT included their brief administration time, limited staff training/administration demands, and automated scoring and data collection with greater precision of measurement. Surprisingly, our analyses did not support drinking-related differences in objective cognitive performance on a decision-making task (IGT), a finding that is inconsistent with prior research in both HIV and heavy drinking populations. 4, 34, 35 However, the real-world significance of impaired IGT performance is unknown, as it has not shown a significant association with functional disability in daily living. 36 The present study had a number of other limitations. We did not have a healthy control group of nondrinkers or seronegative patients against which scores could be compared. To compensate for this, we compared overall patterns in CogState performance to a large sample of normative data collected from healthy individuals. This comparison provided information on the broad cognitive spectrum of HIV+ men and Each column provides the parameter estimates and corresponding 95% confidence intervals for the model of a particular CogState task (indicated by the column heading). Current AUD diagnosis and self-reported drinking level variables were not included in the same model because of multicollinearity, so each model was run twice: once using AUD as the drinking measure and another using self-report as the drinking measure. All covariate parameter estimates displayed in the table (except for self-reported drinking level) are for the model with AUD as the drinking indicator, though there was very little variation in estimates from the models using self-reported drinking. For models fit using logarithmic links, shown estimates have been exponentiated.
Bold indicates significance r0.05. AUD dx indicates alcohol use disorder diagnosis; 95% CI, Wald 95% confidence interval; PHQ-9, Patient Health Questionnaire-9; Ref, reference category.
women who drink alcohol in relation to a non-HIV population. The crosssectional data collection did not allow for inferences of causality. Because the sample lacked HIV disease markers (CD4 count, viral load), immunosuppression and/or uncontrolled neurotoxic processes could also have confounded the results. Further, we did not obtain information on the number of years since the infection was acquired. Thus, the direct effects of HIV disease progression on neurocognition 37 could have masked the relationship between cognition and both alcohol drinking level and AUD symptoms. It is also worth noting that our sample was recruited almost exclusively from medical settings and HIV treatment centers, and active engagement with a course of HAART treatment was an inclusion criterion for study participation. Together, these factors provide some support for the notion that the neurovirulent aspects of HIV were controlled to a greater degree than if recruitment took place from an untreated population. Future neuropsychological studies of the effects of alcohol in HIV+ individuals should include markers of infection and should assess multiple factors longitudinally.
Despite these limitations, the study had a number of important strengths. First, our study examined several participant characteristics and behaviors as potential predictors of cognitive performance, including depression score, premorbid intellectual functioning, and recent cannabis use. Second, we added to the relatively sparse body of literature on the effects of alcohol on cognition in HIV. We expanded the existing literature by utilizing a comprehensive battery of objective measures of cognitive performance in multiple domains, ranging from foundational tasks, such as basic attention and reaction time, to more complex tasks such as EF and decision-making. Third, we compared participants' performance on the CogState battery to that of a normative sample, which showed generally that the HIV+ individuals' neurocognitive performance was largely unimpaired, but that psychomotor speed was significantly lower than expected in view of the normative data. Finally, we used a reliable and valid measure of recent drinking, the TLFB, [28] [29] [30] rather than a self-report questionnaire of unknown reliability or validity.
Further neuropsychological research is needed on the complex interplay among the course of HIV-related disease, alcohol consumption level, and premorbid/demographic characteristics. Study samples should be large enough to provide adequate statistical power and longitudinal designs should be tailored to allow a consideration of each factor's unique contribution to variance in cognitive performance. Most importantly, the clinical and functional implications of detectable cognitive changes among individuals with HIV require further investigation.
APPENDIX: DESCRIPTION OF COGSTATE TASKS
K Detection Task (DET)-measures psychomotor speed/reaction time.
Participants must press a response key as soon as they detect a stimulus (a playing card switching from facedown to face-up). The software measured the response time to detect each event. K Identification Task (ID)-measures basic attention. An event occurs in the center of the computer screen (card turns face up) and the participant must decide whether the event meets a predefined and unchanging criterion (whether the suit on the card is red). The software measured the response time for an accurate response. K One-Back Memory Task (ONB)-measures working memory. The participant is shown a single stimulus in the center of the computer screen (card turns face up). He/she must decide whether the current card matches the card seen on the immediately previous trial. The software measured the accuracy of each response. K Card Learning Task (CL)-measures visual learning and memory. This is a continuous visual memory task in which playing cards are displayed on the screen 1 at a time, and participants were asked to indicate ''yes'' or ''no'' as to whether they had seen the card before during the present task. Several target cards were repeated throughout. The software measured the accuracy of responses. K Shopping List Task, Immediate and Delayed Recall Trials (SL; SL-R)-measures verbal learning and memory. Participants were read a list of 12 words at the rate of 1 word every 2 seconds. After the list was completed, the participant was asked to recall as many of the words as possible. This process was repeated for a second and third trial. After a 20 to 30 minutes delay, the participant was again asked to recall as many words as possible, without being read the list again. Total number of words recalled at initial recall (T1+ T2+ T3) and delayed recall comprised the 2 outcome scores for this task. K Groton Maze Learning Test (GMLT)-measures EF. Participants were shown a 10 Â 10 grid of tiles on the computer screen, in which a 28-step pathway is hidden among the 100 possible locations, with the start and finish locations in the top left and bottom right of the grid, respectively. Each participant was instructed to move 1 step from the start location and to continue ahead, 1 tile at a time, toward the end. The participant moved by clicking the mouse on each desired tile. After each move, the computer indicated whether it was correct or incorrect. If the choice was incorrect, the participant was required to return to the last correct location and then make a different tile choice to advance toward the end. While moving through the hidden maze, participants were required to adhere to 2 rules: no diagonal moves or touching the same tile twice in succession and no moving backwards along the pathway. Thus, the participants learned the 28-step pathway though the maze on the basis of this trial and error feedback. Once completed, the same maze was completed for 4 more trials, offering individuals the chance to improve if they could learn the pathway just completed. The software measured the total number of errors across all 5 trials.
